CIK 0001158780
- Non-accelerated filer
- Smaller reporting company
Pluri Inc.
Sign in to watch- Ticker
- PLUR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 980351734
- Phone
- +972 747107171
- Business address
- MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
- Former names
- PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Co-CEO & Chairman acquired 550,000 shares (grant or award)
- 4 Grant or award Co-CEO & President acquired 530,000 shares (grant or award)
- 4 Grant or award Director acquired 113,250 shares (grant or award)
- 4 Grant or award Director acquired 67,500 shares (grant or award)
- 4 Grant or award Director acquired 111,750 shares (grant or award)
- 4 Grant or award Director acquired 81,000 shares (grant or award)
- 4 Grant or award Director acquired 99,750 shares (grant or award)
- 4 Grant or award Director acquired 81,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 160,000 shares (grant or award)
- 4 Grant or award Director acquired 113,250 shares (grant or award)
- 4 Open-market sale Director sold 45,873 shares at $1.48 ($67,892)
- 4 Open-market sale Director sold 23,818 shares at $1.50 ($35,727)
- 4 Grant or award Director acquired 90,000 shares (grant or award)
- 4 Grant or award Director acquired 90,000 shares (grant or award)
- 4 Grant or award Director acquired 133,000 shares (grant or award)
- 4 Grant or award Director acquired 133,000 shares (grant or award)
- 4 Grant or award Director acquired 131,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 110,000 shares (grant or award)
Page 5 of 18 · 352 filings